Oppenheimer & CO Inc Axogen, Inc. Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
A detailed history of Oppenheimer & CO Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 11,095 shares of AXGN stock, worth $163,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,095Holding current value
$163,540% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXGN
# of Institutions
163Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$60.3 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$47.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$44.3 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$42.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$35.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $623M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...